Tizanidne Hydrochloride
Product Images NDC 67296-1793

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 67296-1793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15 Count (67296 1793)

15 Count (67296 1793)
TIZANIDINE 4MG 15 Capsules. This medication is typically used for muscle spasms. The recommended dose for adults is specified in the package insert. It has an expiration date of 05/21 and should be stored at a controlled temperature. The NDC number is 67296-1793-7, and it is distributed by Redpharm Drug in Eden Prairie, MN. The other numbers seem to be codes or references, and the characters "&", "5og" and "143242X1" are not readable.*
FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

Tiz02 (Tiz02)
Not available.*
FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

Tiz04 (Tiz04)
The text describes the improvement in Ashworth Score with dosages of Tizanidine in a study. The duration of the study was 7 weeks and the endpoint was achieved by the last observation carried forward.*
FDA Label Image

Tiz05new (Tiz05new)

Tiz05new (Tiz05new)
Each capsule of this medication called "Tizanidine Hydrochloride Capsules" contains 2.29 mg of tizanidine hydrochloride which is equal to 2 mg of tizanidine base. This drug is registered under the trademark name "Zanaflex" by Acorda Therapeutics. The recommended dose for this medication can be found in the package insert. Store at temperatures between 25°C to 30°C (59 to 86°F). The drug must be kept out of reach of children and stored in a tight container with a child-resistant closure per USP requirements. This medication is not the same as fizanidine tablets or Zanaflex tablets. The product is manufactured in India by Alkem Laboratories Ltd., and distributed by Ascend Laboratories, LLC based in Parsippany, NJ. Unfortunately, there is unclear or missing information in the text regarding the Unwinding Direction, UV Varnish, and Lot E.Date.*
FDA Label Image

Tiz06new (Tiz06new)

Tiz06new (Tiz06new)
Tizanidine Hydrochloride Capsules are a prescription drug that come in capsules containing 2.29mg of tizaridine hydrochloride equivalent to 2mg of tzanidine base. They are not interchangeable with tizanidine tablets or Zanaflex tablets. The usual dosage and full prescribing information can be found in the package insert. They should be stored at controlled room temperature and kept out of reach of children. These capsules are manufactured by Alkem Laboratories in India and distributed by Ascend Laboratories in the United States. The NDC number is 67877-610-33.*
FDA Label Image

Tiz07 (Tiz07)

Tiz07 (Tiz07)
This is a prescription drug called Tizanidine Hydrochloride Capsule in a 2mg dose. It is manufactured for Ascend Laboratories, LLC and made in India. The lot and expiration dates are displayed but the specific numbers are not available.*
FDA Label Image

Tiz08new (Tiz08new)

Tiz08new (Tiz08new)
This is a label of medication containing tizanidine hydrochloride equivalent to 4mg tizanidine base. The usual dosage requires a reference to the package insert for the hydrochloride capsules. The manufacturer is Alem Laboratories Ltd from Mumbai, India, and distributed by Ascend Laboratories in Parsippany, NJ. The label should be stored at a temperature of 25°C (77°F). The rest of the decipherable text contains batch details and dosage instructions.*
FDA Label Image

Tiz09new (Tiz09new)

Tiz09new (Tiz09new)
Tizanidine Hydrochloride Capsules is a medication that is not interchangeable with tizanidine tablets or Zanaflex™ tablets. Each capsule contains 4.58g tizanidine hydrochloride equivalent to 4mg tizanidine base. It is manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC. The Usual Dosage, prescribing information, and storage instructions are available in the package insert, and it is essential to keep this medication out of reach of children.*
FDA Label Image

Tiz10 (Tiz10)

FDA Label Image

Tiz11new (Tiz11new)

FDA Label Image

Tiz12new (Tiz12new)

Tiz12new (Tiz12new)
This is a description of Tizanidine Hydrochloride Capsules manufactured by Alkem Laboratories Ltd. It consists of 10 capsules and is not interchangeable with tizanidine tablets or Zanaflex tablets. Each capsule contains 6.87 mg of tizanidine hydrochloride equivalent to 6 mg of tizanidine base. The usual dosage should be referred to the package insert for complete prescribing information. These capsules should be stored at 25°C (77°F), with excursions permitted 1 15 to 30°C (59 to 86°F) as per USP controlled room temperature. Acorda Therapeutics Inc. has registered Zanaflex as a trademark. The description also contains information about the distributor.*
FDA Label Image

Tiz13 (Tiz13)

Tiz13 (Tiz13)
This is a prescription drug label for Tizanidine Hydrochloride Capsule. The capsules have a strength of 6 mg and are manufactured by Ascend Laboratories in India. The label includes a lot number and an expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.